UK markets closed
NIKKEI 225
38,923.03 +435.13 (+1.13%) HANG SENG
18,403.04 +323.43 (+1.79%) CRUDE OIL
74.00 -2.99 (-3.88%) GOLD FUTURES
2,371.40 +25.60 (+1.09%) DOW
38,571.03 -115.29 (-0.30%) Bitcoin GBP
53,986.93 +1,051.23 (+1.99%)
PAVmed Inc. (PAVM)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.4500 |
| Open | 1.4770 |
| Bid | 0.0000 x 0 |
| Ask | 1.4900 x 200 |
| Day's range | 1.3850 - 1.4900 |
| 52-week range | 1.3800 - 9.0000 |
| Volume | |
| Avg. volume | 57,153 |
| Market cap | 13.204M |
| Beta (5Y monthly) | 0.83 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -9.0600 |
| Earnings date | 12 Aug 2024 - 16 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.75 |
- GuruFocus.com
PAVmed Inc (PAVM) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Financial ...
Explore PAVmed Inc's strategic initiatives and financial performance, including a significant partnership with Ohio State's James Cancer Hospital and a robust Series B financing round.
PR NewswirePAVmed Provides Business Update and First Quarter 2024 Financial Results
PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid") and Veris Health Inc. ("Veris"), and presented financial results for the Company for the three months ended March 31, 2024.
© 2024 Yahoo. All rights reserved.